Total Payments
$9,659
2024 Payments
$730.98
Companies
32
Transactions
527
Medicare Patients
33,702
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$5,074 (52.5%)
Other$3,800 (39.3%)
Education$537.78 (5.6%)
Travel$246.64 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,074 | 514 | 52.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,800 | 2 | 39.3% |
| Education | $537.78 | 9 | 5.6% |
| Travel and Lodging | $246.64 | 2 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $4,442 | 53 | $0 (2024) |
| Novo Nordisk Inc | $1,506 | 195 | $0 (2024) |
| ABBVIE INC. | $677.19 | 76 | $0 (2024) |
| Astellas Pharma US Inc | $651.10 | 38 | $0 (2023) |
| Abbott Laboratories | $468.72 | 41 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $323.88 | 13 | $0 (2022) |
| Esperion Therapeutics, Inc. | $260.50 | 24 | $0 (2021) |
| Lilly USA, LLC | $195.87 | 23 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $113.94 | 6 | $0 (2024) |
| InSightec,Inc | $110.83 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $730.98 | 53 | Novo Nordisk Inc ($265.58) |
| 2023 | $1,086 | 107 | Novo Nordisk Inc ($325.63) |
| 2022 | $1,014 | 122 | Novo Nordisk Inc ($383.15) |
| 2021 | $1,320 | 121 | AbbVie Inc. ($332.00) |
| 2020 | $2,567 | 55 | PFIZER INC. ($2,183) |
| 2019 | $2,353 | 41 | PFIZER INC. ($2,086) |
| 2018 | $292.59 | 17 | Astellas Pharma US Inc ($224.78) |
| 2017 | $295.66 | 11 | Janssen Pharmaceuticals, Inc ($217.93) |
All Payment Transactions
527 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Endocrinology | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.30 | General |
| 10/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $1.00 | General |
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: Diabetes | ||||||
| 09/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Endocrinology | ||||||
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $1.25 | General |
| 08/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.44 | General |
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Gastroenterology | ||||||
| 07/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Diabetes | ||||||
| 07/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.95 | General |
| 07/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Obesity | ||||||
| 07/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: Obesity | ||||||
| 06/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: PAIN | ||||||
| 05/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 8,105 | 12,376 | $840,260 | $351,069 |
| 2022 | 48 | 8,585 | 13,303 | $888,179 | $378,740 |
| 2021 | 46 | 8,311 | 12,513 | $794,743 | $358,519 |
| 2020 | 54 | 8,701 | 13,211 | $847,933 | $365,951 |
Total Patients
33,702
Total Services
51,403
Medicare Billing
$1.5M
Procedure Codes
194
All Medicare Procedures & Services
194 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 640 | 1,714 | $411,360 | $139,868 | 34.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 513 | 513 | $125,172 | $64,756 | 51.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 593 | 1,055 | $30,595 | $13,831 | 45.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 452 | 459 | $29,835 | $13,290 | 44.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 149 | 150 | $18,075 | $10,776 | 59.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 610 | 1,292 | $12,355 | $10,408 | 84.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 595 | 1,176 | $21,168 | $9,718 | 45.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 530 | 561 | $20,757 | $9,220 | 44.4% |
| 80076 | Liver function blood test panel | Office | 2023 | 595 | 1,065 | $19,170 | $8,524 | 44.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 27 | 27 | $13,041 | $7,619 | 58.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 367 | 695 | $14,595 | $6,553 | 44.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 23 | $10,833 | $4,965 | 45.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 527 | 554 | $11,080 | $4,890 | 44.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 531 | 610 | $10,370 | $4,636 | 44.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 151 | 152 | $5,928 | $4,583 | 77.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 24 | 24 | $7,753 | $3,879 | 50.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 24 | 24 | $7,896 | $3,871 | 49.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 21 | 88 | $7,744 | $3,844 | 49.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 180 | 180 | $7,200 | $3,406 | 47.3% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 130 | 214 | $5,136 | $2,618 | 51.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 55 | 55 | $6,765 | $2,059 | 30.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 300 | 361 | $4,693 | $2,033 | 43.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 57 | $3,420 | $1,960 | 57.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 299 | 360 | $3,960 | $1,825 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $3,740 | $1,478 | 39.5% |
About Dr. Juan Aponte, MD
Dr. Juan Aponte, MD is a Internal Medicine healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376526947.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Juan Aponte, MD has received a total of $9,659 in payments from pharmaceutical and medical device companies, with $730.98 received in 2024. These payments were reported across 527 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,074).
As a Medicare-enrolled provider, Aponte has provided services to 33,702 Medicare beneficiaries, totaling 51,403 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 194 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lynchburg, VA
- Active Since 11/28/2005
- Last Updated 07/13/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1376526947
Products in Payments
- COLOGUARD (Device) $4,206
- Ozempic (Drug) $648.85
- Rybelsus (Drug) $304.68
- VRAYLAR (Drug) $260.53
- NEXLETOL (Drug) $260.50
- UBRELVY (Drug) $246.62
- XARELTO (Drug) $226.90
- FREESTYLE LIBRE 3 (Device) $193.71
- Wegovy (Drug) $179.69
- FREESTYLE LIBRE 2 (Device) $175.32
- QULIPTA (Drug) $152.77
- MYRBETRIQ (Drug) $124.95
- GVOKE HYPOPEN (Drug) $113.94
- Exablate (Device) $110.83
- NURTEC ODT (Drug) $108.83
- APTIOM (Drug) $105.75
- INVOKANA (Drug) $90.96
- JARDIANCE (Drug) $90.05
- FreeStyle Libre 2 (Device) $84.65
- TROKENDI XR (Drug) $81.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lynchburg
Dr. Julia Mchugh, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $31,277
Internal Medicine $31,277
Dr. Patrick Kenny, Do, DO
Internal Medicine — Payments: $10,141
Internal Medicine $10,141
Richard Miller, Md, MD
Internal Medicine — Payments: $8,691
Internal Medicine $8,691
Dr. Kenneth Musana, Md, MD
Internal Medicine — Payments: $8,380
Internal Medicine $8,380
Dr. Evan Ownby, Md, MD
Internal Medicine — Payments: $3,602
Internal Medicine $3,602
Dr. Michael Cook, Md, MD
Internal Medicine — Payments: $3,493
Internal Medicine $3,493